Evidence map›Paper›PMID 34456409›Full record

ArticleEnfermedades infecciosas y microbiologia clinica2023

Healthcare outcomes in patients with HIV infection at a tertiary hospital during the COVID-19 pandemic.

Víctor Quirós-González, Rafael Rubio, Federico Pulido, David Rial-Crestelo, Carlos Martín-Jurado, María Ángeles Hernández-Ros, Elena Ana López-Jiménez, José Miguel Ferrari, José Manuel Caro-Teller, Óscar Pinar and 4 more

Open access · greenAbstract read
In one paragraph

Article in Enfermedades infecciosas y microbiologia clinica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Víctor Quirós-GonzálezDirección de Planificación, Hospital Universitario 12 de Octubre, Madrid, Spain.
Rafael RubioUnidad de Infección VIH, Hospital Universitario 12 de Octubre, Madrid, Spain.
Federico PulidoUnidad de Infección VIH, Hospital Universitario 12 de Octubre, Madrid, Spain.
David Rial-CresteloUnidad de Infección VIH, Hospital Universitario 12 de Octubre, Madrid, Spain.
Carlos Martín-JuradoServicio de Análisis de Información y Control de Gestión, Hospital Universitario 12 de Octubre, Madrid, Spain.
María Ángeles Hernández-RosServicio de Análisis de Información y Control de Gestión, Hospital Universitario 12 de Octubre, Madrid, Spain.
Elena Ana López-JiménezServicio de Análisis Clínicos, Hospital Universitario 12 de Octubre, Madrid, Spain.
José Miguel FerrariServicio de Farmacia, Hospital Universitario 12 de Octubre, Madrid, Spain.
José Manuel Caro-TellerServicio de Farmacia, Hospital Universitario 12 de Octubre, Madrid, Spain.
Óscar PinarServicio de Farmacia, Hospital Universitario 12 de Octubre, Madrid, Spain.
Miguel Pedrera-JiménezServicio de Informática, Hospital Universitario 12 de Octubre, Madrid, Spain.
Noelia García-BarrioServicio de Informática, Hospital Universitario 12 de Octubre, Madrid, Spain.
Pablo SerranoDirección de Planificación, Hospital Universitario 12 de Octubre, Madrid, Spain.
José Luis BernalServicio de Análisis de Información y Control de Gestión, Hospital Universitario 12 de Octubre, Madrid, Spain.
Hospital Universitario 12 De Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic has affected the care of patients with other diseases. Difficulty in access to healthcare during these months has been especially relevant for persons with HIV infection (PWH). This study therefore sought to ascertain the clinical outcomes and effectiveness of the measures implemented among PWH in a region with one of the highest incidence rates in Europe. Methods: Retrospective, observational, pre-post intervention study to compare the outcomes of PWH attended at a high-complexity healthcare hospital from March to October 2020 and during the same months across the period 2016-2019. The intervention consisted of home drug deliveries and preferential use of non face-to-face consultations. The effectiveness of the measures implemented was determined by reference to the number of emergency visits, hospitalisations, mortality rate, and percentage of PWH with viral load >50 copies, before and after the two pandemic waves. Results: A total of 2760 PWH were attended from January 2016 to October 2020. During the pandemic, there was a monthly mean of 106.87 telephone consultations and 2075 home deliveries of medical drugs dispensed to ambulatory patients. No statistically significant differences were found between the rate of admission of patients with COVID-HIV co-infection and that of the remaining patients (1172.76 admissions/100,000 population vs. 1424.29, Conclusion: Our results show that the strategies implemented during the first 8 months of the pandemic prevented any deterioration in the control and follow-up parameters routinely used on PWH. Furthermore, they contribute to the debate about how telemedicine and telepharmacy can fit into future healthcare models.

Indexed as

COVID-19HIVTelemedicineTelepharmacy

Identifiers

PMID34456409
PMCPMC8380489
OpenAlexW3194852397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.